Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.
Schoppet
Michael
M
Sattler
Alexander M
AM
Schaefer
Juergen R
JR
Hofbauer
Lorenz C
LC
D000328:Adult; D000368:Aged; D017209:Apoptosis / Q000502:physiology; D050197:Atherosclerosis / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*
D015415:Biomarkers; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor; C505639:TNFRSF10B protein, human; C506030:TNFRSF11B protein, human